August 11th 2021
Alison J. Moskowitz, MD, discusses the challenges of intensifying treatment in Hodgkin lymphoma.
January 21st 2020
Alison J. Moskowitz, MD, discusses important updates in Hodgkin lymphoma.
March 30th 2018
Alison J. Moskowitz, MD, clinical director, Lymphoma Inpatient Unit, Memorial Sloan Kettering Cancer Center, discusses the data that led to the approval of brentuximab vedotin (Adcetris) in patients with cutaneous T-cell lymphoma (CTCL).